Stable Expression of Human Thyrotropin Receptor in HEK 293T Cells
Abstract
To establish a strain of eukaryotic cells with overexpressed human thyrotropin receptor (hTSHR) for the development of anti-thyroid drugs. Methods?GV266 vector and hTSHR gene were digested by AgeⅠ/NheⅠ. Plasmids expressing GV266-hTSHR were constructed using T4 ligase and then transfected into 293T cells. The expression of hTSHR was determined by Western blot. Packaging plasmids were built in the 293T cells with Opti-MEM, Lipofectamine 2000 and helper plasmid. The titer of the packaging plasmids was determined with qPCR. The packaging plasmids and the plasmids expressing GV266-hTSHR were co-transfected into 293T cells to obtain a strain of cells (GV266-hTSHR-293T) with stable expression of hTSHR. The GV266-hTSHR-293T stain was detected by green fluorescent protein (GFP) fluorescence. Results? The DNA sequence of GV266-hTSHR matched that of hTSHR. The Western blot showed a 62×10 3 target band. The titer of packaging plasmids reached 2×108 TU/mL. The GV266-hTSHR-293T cells were visible under GFP fluorescence. Conclusion? HEK 293T cells with stable expression of hTSHR was established.
Keywords: Human thyrotropin receptor, Lentiviral vector, HEK 293T cell, Graves disease
Full Text:
PDFReferences
Bjorkholm M, Pisa P. Arver S, et al. Haematologic effects of granulocyte-macrophage colony stimulating factor in a patient with thiamazole-induced agranulocytosis. J Intern Med. 1992; 232(5);443-445.
Biswas N. Ahn YH. Goldman JM. et al. Aplastic anemia associated with antithyroid drugs. Am J Med Sci, 1991; 301 (3):190-194.
Memi E, Karras S, Tzotzas T, et al. Propylthiouracil hepatitis: report of a case and extensive review of the literature. J Pediatr Endocrinol Metab,2012;25(3-4);331 -343.
Sanders J. Jeffreys J. Depraetere H. et al. Characteristics of a human monoclonal autoantibody to the thyrotropin receptor; sequence structure and function. Thyroid, 2004; 14 (8): 560- 570.
Sanders P, Young S, Sanders J, et al. Crystal structure of the TSH receptor ( TSHR) bound to a blocking-type TSHR autoantibody. J Mol Endocrinol.2011;46(2);81-99.
Nunez Miguel R, Sanders J, Chirgadze DY. et al. Thyroid stimulating autoantibody M22 mimics TSH binding to the TSH receptor leucine rich domain; a comparative structural study of protein-protein interactions. J Mol Endocrinol, 2009; 42 ( 5 ) :
Neumann S. Kleinau G, Costanzi S. et al. A low-molecular- weight antagonist for the human thyrotropin receptor with therapeutic potential for hyperthyroidism. Endocrinology. 2008;149(12):5945-5950.
Tsui S. Naik V, Hoa N. et al. Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors; a tale of two antigens implicated in Graves’ disease. J Immunol,2008; 181 (6) s4397-4405.
Fukushima H. Mizutani M. Imamura K. et al. Development of a novel preparation method of recombinant proieoliposomes using baculovirus gene expression systems. J Biochem, 2008; 144(6):763-770.
Agretti P. Chiovato L, De Marco G, et al. Real-time PCR provides evidence for thyrotropin receptor mRNA expression in orbital as well as in extraorbital tissues. Eur J Endocrinol, 2002;147(6);733-739.
Dutton CM. Joba W. Spitzweg C, et al. Thyrotropin receptor expression in adrenal, kidney, and thymus. Thyroid, 1997; 7 (6);879-884.
Sellitti DF, Akamizu T, Doi SQ, et al. Renal expression of two ‘ thyroid-specific ’ genes; thyrotropin receptor and thyroglobulin. Exp Nephrol,2000;8(4-5);235-243.
Balm RS, Dutton CM, Natt N, et al. Thyrotropin receptor expression in Graves f orbital adipose/connective tissues: potential autoantigen in Graves 9 ophthalmopathy. J Clin Endocrinol Metab, 1998;83( 3): 998-1002.
Bhattacharyya KK, Coenen MJ, Bahn RS. Thyroid transcription factor-1 in orbital adipose tissues; potential role in orbital thyrotropin receptor expression. Thyroid.2005; 15(5): 422-426.
Lu S, Guan Q. Liu Y, et al. Role of extrathyroidal TSHR expression in adipocyte differentiation and its association with obesity. Lipids Health Dis,2012; 11; 17.
Refbacks
- There are currently no refbacks.
